Home > Media KIt > News Room

Unaudited Financial Results For the Quarter ended 31st December, 2010
Sr. No. Particulars (Rs. in Lacs)
Quarter ended  9 Months ended Year ended
31.12.10 31.12.09 31.12.10 31.12.09 31.03.10
(Unaudited) (Unaudited) (Audited)
1(a) Net Sales/Income from Operations 5430.34 4182.28 16014.49 14115.93 19592.89
  (b) Other Operating Income  1.09 1.02  4.56 209.36 23.27
  Total Net Operating Income (1a+1b) 5431.43 4183.30 16019.05 14325.29 19616.16
2 Expenditure          
  a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress 144.20 (157.61) (259.18) (248.05) (504.84)
  b)  Consumption of Raw Materials 3517.49 2890.19 10983.71 10046.87 13350.19
  c)  Employee Cost 683.45 555.63 1995.70 1616.10 2162.43
  d)  Depreciation and Amortisation 1163.40 1144.41 3457.93 3420.11 4562.86
  e)  Other Expenditure 934.06 746.28 2675.92 2181.57 3248.75
  Total Expenditure 6442.60 5178.90 18854.08 17016.60 22819.39
3 Profit/(Loss) from Operations before other Income, Interest & Exceptional Items (1-2)  (1,011.17) (995.60) (2835.03) (2691.31) (3203.23)
4  Other Income   -    -    -    -    -  
5 Profit / (Loss) before Interest and Exceptional Items (3+4)  (1,011.17) (995.60) (2835.03) (2691.31) (3203.23)
6  Interest   143.21 93.92 457.82 180.67 356.59
7 Profit / (Loss) after Interest but before Exceptional Items (5-6) (1154.38) (1089.52) (3292.85) (2871.98) (3559.82)
8  Exceptional Items - Income/(Expense)  -    -    -    -    -  
9 Profit / (Loss) from Ordinary Activities before Tax (7-8) (1154.38) (1089.52) (3292.85) (2871.98) (3559.82)
10  Tax Expense   -    -    -    -    -  
11 Profit / (Loss) from Ordinary Activities after Tax (9-10) (1154.38) (1089.52) (3292.85) (2871.98) (3559.82)
12  Extraordinary Items-Income/(Expense)  -    -    -   3385.77 3385.77
13 Net Profit /(Loss) for the period   (1154.38) (1089.52) (3292.85) 513.79 (174.05)
14  Paid-up Equity Share Capital of Face Value of Rs.2/- each 8995.86 8995.86 8995.86 8995.86 8995.86
15 Reserves excluding Revaluation reserves  -    -    -    -   24275.49
16 a) Earning Per Share before Extraordinary Items (in Rs.) -                          
   - Basic & Diluted  (0.26) (0.24)  (0.73) (0.71) (0.86)
  b) Earning Per Share after Extraordinary Items (in Rs.) -                                             
   - Basic & Diluted  (0.26) (0.24)  (0.73) 0.13 (0.04)
17 Public Shareholding          
   - Number of Shares 294454615 294454615 294454615 294454615 294454615
   - Percentage of shareholding 65.46 65.46 65.46 65.46 65.46
18 Promoters and Promoter Group Shareholding          
  a) Pledged / Encumbered          
   - Number of Shares 610000 610000 610000 610000 610000
   - Percentage of shares (as a % of the total shareholding of promoters and promoter group) 0.39 0.39 0.39 0.39 0.39
   - Percentage of shares (as a % of the total share capital of the company) 0.14 0.14 0.14 0.14 0.14
  b) Non-encumbered          
   - Number of Shares 154761588 154761588 154761588 154761588 154761588
   - Percentage of shares (as a % of the total shareholding of promoters and promoter group)  99.61 99.61 99.61 99.61 99.61
   - Percentage of shares (as a % of the total share capital of the company) 34.40 34.40 34.40 34.40 34.40

Notes:

  1. The above results were reviewed by the audit committee and have been approved by the Board of Directors in its meeting held on 11th February, 2011. A limited review of the same has been carried out by the statutory auditors.
  2. The Company is exclusively engaged in the Pharmaceutical Business segment. Capital Employed as on December 31, 2010 is Rs.52673.27 Lacs.
  3. Consolidated Income from Operatitons, Loss after tax and EPS for the quarter ended December 31, 2010 stands at Rs.5876.58 Lacs, Rs.1213.37 Lacs & Rs.(0.27) respectively.
  4. There were no investor complaints pending at the beginning & at the end of the quarter. During the quarter, 21 shareholder's complaints were received and resolved.
For and on behalf of the Board
Place : New Delhi
Date : 11.02.2011
(Sushil Suri)
Chairman & Managing Director